William Greenhalf

17.4k total citations · 2 hit papers
110 papers, 5.2k citations indexed

About

William Greenhalf is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, William Greenhalf has authored 110 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Oncology, 37 papers in Surgery and 37 papers in Molecular Biology. Recurrent topics in William Greenhalf's work include Pancreatic and Hepatic Oncology Research (74 papers), Pancreatitis Pathology and Treatment (30 papers) and Cancer Genomics and Diagnostics (25 papers). William Greenhalf is often cited by papers focused on Pancreatic and Hepatic Oncology Research (74 papers), Pancreatitis Pathology and Treatment (30 papers) and Cancer Genomics and Diagnostics (25 papers). William Greenhalf collaborates with scholars based in United Kingdom, Germany and United States. William Greenhalf's co-authors include John P. Neoptolemos, Eithne Costello, Jörg Kleeff, Daniel H. Palmer, Patrick Michl, Bhabatosh Chaudhuri, Paula Ghaneh, Nathan Howes, Christine Stephan and Christopher Halloran and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

William Greenhalf

105 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic developments in pancreatic cancer: current and future perspectives

2018 818 citations John P. Neoptolemos, Jörg Kleeff et al. profile →
Early detection of pancreatic cancer

2020 323 citations Stephen P. Pereira, Lucy Oldfield et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Greenhalf United Kingdom	36	3.0k	2.1k	1.5k	1.3k	625	110	5.2k
Eithne Costello United Kingdom	43	3.0k 1.0×	3.2k 1.5×	1.9k 1.3×	880 0.7×	817 1.3×	111	6.3k
Masaaki Oka Japan	43	1.9k 0.6×	2.5k 1.2×	1.2k 0.8×	837 0.6×	996 1.6×	160	5.4k
James C. Cusack United States	35	2.7k 0.9×	2.6k 1.3×	1.3k 0.8×	787 0.6×	567 0.9×	89	5.1k
Julie E. Bauman United States	36	2.7k 0.9×	2.6k 1.2×	1.2k 0.8×	1.2k 0.9×	815 1.3×	140	6.6k
Elena Ioana Braicu Germany	40	1.7k 0.6×	2.1k 1.0×	1.2k 0.8×	1.1k 0.8×	768 1.2×	303	5.4k
Shubham Pant United States	32	2.7k 0.9×	1.5k 0.7×	1.2k 0.8×	753 0.6×	701 1.1×	279	4.5k
Yoshinaga Okugawa Japan	43	2.5k 0.8×	3.5k 1.7×	2.6k 1.8×	1.0k 0.8×	649 1.0×	237	6.9k
Liang Liu China	39	2.6k 0.9×	2.3k 1.1×	1.7k 1.1×	686 0.5×	896 1.4×	165	5.3k
Zhao–You Tang China	38	1.5k 0.5×	2.4k 1.1×	1.8k 1.2×	923 0.7×	622 1.0×	164	5.7k
Kieran Sheahan Ireland	40	2.9k 0.9×	1.5k 0.7×	1.1k 0.7×	1.5k 1.2×	600 1.0×	175	5.5k

Countries citing papers authored by William Greenhalf

Since Specialization

Citations

This map shows the geographic impact of William Greenhalf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Greenhalf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Greenhalf more than expected).

Fields of papers citing papers by William Greenhalf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Greenhalf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Greenhalf. The network helps show where William Greenhalf may publish in the future.

Co-authorship network of co-authors of William Greenhalf

This figure shows the co-authorship network connecting the top 25 collaborators of William Greenhalf. A scholar is included among the top collaborators of William Greenhalf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Greenhalf. William Greenhalf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Turtle, Lance, Thomas M Drake, Mathew Thorpe, et al.. (2024). Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study. The Lancet Oncology. 25(5). 636–648. 5 indexed citations

Haldenby, Sam, Anna Fowler, Katie Bullock, et al.. (2023). Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways. Scientific Reports. 13(1). 6681–6681. 5 indexed citations

Masson, Emmanuelle, Jian‐Min Chen, Claude Férec, et al.. (2023). Genetic and functional analysis of chymotrypsin-like protease (CTRL) in chronic pancreatitis. Pancreatology. 23(8). 957–963. 2 indexed citations

Oldfield, Lucy, A.G. Evans, Claire Jenkinson, et al.. (2022). Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. EBioMedicine. 75. 103802–103802. 23 indexed citations

Oldfield, Lucy, Robert N. Hanson, Richard Jackson, et al.. (2022). United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer. BMJ Open. 12(10). e068010–e068010. 10 indexed citations

Barrera, Lawrence N., A.G. Evans, Brian R. Lane, et al.. (2020). Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties. Cancer Research. 80(13). 2861–2873. 25 indexed citations

Korenbaum, Clément, Chrystelle Colas, Florence Coulet, et al.. (2019). Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. Clinical Genetics. 96(6). 579–584. 5 indexed citations

Olesen, Søren Schou, Henrik Krarup, Jakob Lykke Poulsen, et al.. (2019). Pancreas‐specific plasma amylase for assessment and diagnosis of chronic pancreatitis: New insights on an old topic. United European Gastroenterology Journal. 7(7). 955–964. 14 indexed citations

Lobo, Víctor J. Sánchez‐Arévalo, Rosy Favicchio, William Greenhalf, et al.. (2016). Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors. Molecular Cancer Therapeutics. 15(2). 323–333. 27 indexed citations

10.

Botla, Sandeep K., Soniya Savant, Pouria Jandaghi, et al.. (2016). Early Epigenetic Downregulation of microRNA-192 Expression Promotes Pancreatic Cancer Progression. Cancer Research. 76(14). 4149–4159. 67 indexed citations

11.

Radon, Tomasz P., Nathalie J. Massat, Richard S. Jones, et al.. (2015). Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. Clinical Cancer Research. 21(15). 3512–3521. 148 indexed citations

12.

Cioffi, Michele, Sara Maria David Trabulo, Manuel Hidalgo, et al.. (2015). Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms. Clinical Cancer Research. 21(10). 2325–2337. 182 indexed citations

13.

Shaw, Victoria, Katie Bullock, & William Greenhalf. (2015). Single-Nucleotide Polymorphism to Associate Cancer Risk. Methods in molecular biology. 1381. 93–110. 10 indexed citations

14.

Jenkinson, C, Victoria A. Elliott, Usha Menon, et al.. (2014). Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer. Journal of Proteomics. 113. 400–402. 34 indexed citations

15.

Vimalachandran, Dale, William Greenhalf, Christopher C. Thompson, et al.. (2005). High Nuclear S100A6 (Calcyclin) Is Significantly Associated with Poor Survival in Pancreatic Cancer Patients. Cancer Research. 65(8). 3218–3225. 114 indexed citations

16.

Cohn, Jonathan, John P. Neoptolemos, Jinong Feng, et al.. (2005). Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers. Human Mutation. 26(4). 303–307. 70 indexed citations

17.

Howes, Nathan, Markus M. Lerch, William Greenhalf, et al.. (2004). Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clinical Gastroenterology and Hepatology. 2(3). 252–261. 397 indexed citations

18.

Howes, Nathan, William Greenhalf, Deborah Stocken, & John P. Neoptolemos. (2004). Cationic trypsinogen mutations and pancreatitis. Gastroenterology Clinics of North America. 33(4). 767–787. 24 indexed citations

19.

Howes, Nathan, William Greenhalf, & John P. Neoptolemos. (2000). SCREENING FOR EARLY PANCREATIC DUCTAL ADENOCARCINOMA IN HEREDITARY PANCREATITIS. Medical Clinics of North America. 84(3). 719–738. 23 indexed citations

20.

Greenhalf, William, Christine Stephan, & Bhabatosh Chaudhuri. (1996). Role of mitochondria and C‐terminal membrane anchor of Bcl‐2 in Bax induced growth arrest and mortality in Saccharomyces cerevisiae. FEBS Letters. 380(1-2). 169–175. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact